Walls Laura Ellen, Martinez José L, Rios-Solis Leonardo
Institute for Bioengineering, School of Engineering, University of Edinburgh, Edinburgh EH9 3DW, UK.
Centre for Synthetic and Systems Biology (SynthSys), University of Edinburgh, Edinburgh EH9 3BF, UK.
Microorganisms. 2022 Jan 13;10(1):163. doi: 10.3390/microorganisms10010163.
The recent technological advancements in synthetic biology have demonstrated the extensive potential socio-economic benefits at laboratory scale. However, translations of such technologies to industrial scale fermentations remains a major bottleneck. The existence and lack of understanding of the major discrepancies in cultivation conditions between scales often leads to the selection of suboptimal bioprocessing conditions, crippling industrial scale productivity. In this study, strategic design of experiments approaches were coupled with state-of-the-art bioreactor tools to characterize and overcome nutritional stress for the enhanced production of precursors to the blockbuster chemotherapy drug, Taxol, in cell factories. The batch-to-batch variation in yeast extract composition was found to trigger nutritional stress at a mini-bioreactor scale, resulting in profound changes in cellular morphology and the inhibition of taxane production. The cells shifted from the typical budding morphology into striking pseudohyphal cells. Doubling initial yeast extract and peptone concentrations (2×YP) delayed filamentous growth, and taxane accumulation improved to 108 mg/L. Through coupling a statistical definitive screening design approach with the state-of-the-art high-throughput micro-bioreactors, the total taxane titers were improved a further two-fold, compared to the 2×YP culture, to 229 mg/L. Filamentous growth was absent in nutrient-limited microscale cultures, underlining the complex and multifactorial nature of yeast stress responses. Validation of the optimal microscale conditions in 1L bioreactors successfully alleviated nutritional stress and improved the titers to 387 mg/L. Production of the key Taxol precursor, T5αAc, was improved two-fold to 22 mg/L compared to previous maxima. The present study highlights the importance of following an interdisciplinary approach combining synthetic biology and bioprocessing technologies for effective process optimization and scale-up.
合成生物学领域最近的技术进步已在实验室规模展现出广泛的潜在社会经济效益。然而,将此类技术转化为工业规模发酵仍然是一个主要瓶颈。不同规模培养条件下主要差异的存在以及对其缺乏了解,常常导致选择次优的生物加工条件,削弱了工业规模的生产力。在本研究中,实验设计的策略方法与最先进的生物反应器工具相结合,以表征并克服营养应激,从而在细胞工厂中提高重磅化疗药物紫杉醇前体的产量。发现酵母提取物成分的批次间差异会在微型生物反应器规模引发营养应激,导致细胞形态发生深刻变化并抑制紫杉烷的产生。细胞从典型的出芽形态转变为显著的假菌丝细胞。将初始酵母提取物和蛋白胨浓度加倍(2×YP)可延迟丝状生长,紫杉烷积累量提高到108毫克/升。通过将统计确定性筛选设计方法与最先进的高通量微型生物反应器相结合,与2×YP培养相比,总紫杉烷滴度进一步提高了两倍,达到229毫克/升。在营养受限的微型培养中不存在丝状生长,这突出了酵母应激反应的复杂和多因素性质。在1升生物反应器中对最佳微型规模条件进行验证,成功缓解了营养应激,并将滴度提高到387毫克/升。关键紫杉醇前体T5αAc的产量相比之前的最高值提高了两倍,达到22毫克/升。本研究强调了采用合成生物学和生物加工技术相结合的跨学科方法进行有效工艺优化和放大的重要性。